Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases Indian Medical PG Practice Questions and MCQs

Question 91: Which of the following medications is used to directly relax the lower esophageal sphincter?

A. Diphenoxylate
B. Famotidine
C. Granisetron
D. Isosorbide dinitrate (Correct Answer)

Explanation: **Explanation:** **Correct Option: D. Isosorbide dinitrate** Isosorbide dinitrate is a **nitrate** that acts as a nitric oxide (NO) donor. In the gastrointestinal tract, NO is the primary inhibitory neurotransmitter responsible for the relaxation of smooth muscles. It stimulates guanylyl cyclase, increasing cGMP levels, which leads to the dephosphorylation of myosin light chains and subsequent relaxation of the **lower esophageal sphincter (LES)**. Clinically, nitrates (along with Calcium Channel Blockers like Nifedipine) are used as pharmacological interventions to reduce LES pressure in patients with **Achalasia Cardia** who are not candidates for surgery or pneumatic dilation. **Incorrect Options:** * **A. Diphenoxylate:** An opioid derivative used as an **anti-diarrheal** agent. It acts on μ-opioid receptors in the gut to decrease intestinal motility; it does not relax the LES. * **B. Famotidine:** An **H2-receptor antagonist** that reduces gastric acid secretion. It is used in GERD and peptic ulcer disease but has no direct effect on LES tone. * **C. Granisetron:** A selective **5-HT3 receptor antagonist** used primarily as an anti-emetic (especially for chemotherapy-induced nausea and vomiting). It acts on the chemoreceptor trigger zone (CTZ) and vagal afferents. **High-Yield Clinical Pearls for NEET-PG:** * **Achalasia Cardia Treatment:** Pharmacotherapy is the least effective long-term treatment. Gold standard treatments include **Heller’s Myotomy** or **POEM** (Peroral Endoscopic Myotomy). * **Botulinum Toxin:** Can be injected endoscopically into the LES to inhibit acetylcholine release, thereby inducing relaxation in Achalasia. * **Drug-Induced LES Relaxation:** Other drugs that decrease LES pressure (and may worsen GERD) include Theophylline, Anticholinergics, and Progesterone.

Question 92: A patient with a bleeding duodenal ulcer is managed conservatively. Which of the following treatment regimens is most likely to be successful?

A. Proton pump inhibitor (PPI) + Bismuth + Tetracycline + Metronidazole
B. Proton pump inhibitor (PPI) + Amoxicillin + Clarithromycin (Correct Answer)
C. Proton pump inhibitor (PPI) + Clarithromycin + Bismuth
D. Proton pump inhibitor (PPI) + Metronidazole

Explanation: **Explanation:** The primary goal in managing a duodenal ulcer (DU) is the eradication of *Helicobacter pylori*, which is responsible for over 90% of DU cases. Eradication significantly reduces the risk of ulcer recurrence and complications like re-bleeding. **Why Option B is Correct:** The standard first-line treatment for *H. pylori* is **Triple Therapy**, consisting of a **Proton Pump Inhibitor (PPI)** plus two antibiotics: **Amoxicillin** and **Clarithromycin**. * **PPI:** Increases gastric pH, which enhances the stability and efficacy of the antibiotics. * **Amoxicillin & Clarithromycin:** Provide synergistic bactericidal action against *H. pylori*. This regimen is preferred due to its high efficacy and relatively low side-effect profile compared to bismuth-based therapies. **Analysis of Incorrect Options:** * **Option A:** This is **Bismuth-based Quadruple Therapy**. While highly effective, it is typically reserved as a second-line treatment or used in areas with high clarithromycin resistance. * **Option C:** This is an incomplete regimen. Bismuth is rarely used with only one antibiotic (Clarithromycin) without a second antibiotic like Metronidazole or Tetracycline. * **Option D:** Dual therapy (PPI + one antibiotic) is insufficient for eradication and leads to high rates of antibiotic resistance and treatment failure. **High-Yield NEET-PG Pearls:** * **Duration:** Triple therapy is typically administered for **10–14 days**. * **Penicillin Allergy:** If the patient is allergic to penicillin, Amoxicillin is replaced with **Metronidazole**. * **Sequential Therapy:** Involves 5 days of PPI + Amoxicillin, followed by 5 days of PPI + Clarithromycin + Tinidazole. * **Urease Breath Test:** The gold standard non-invasive test to confirm eradication (performed 4 weeks after completing therapy).

Question 93: Which of the following is the most common adverse effect of omeprazole?

A. Nausea (Correct Answer)
B. Constipation
C. Jaundice
D. Black stools

Explanation: **Explanation:** **Omeprazole** is a Proton Pump Inhibitor (PPI) that irreversibly inhibits the $H^+/K^+$ ATPase pump in gastric parietal cells. It is generally well-tolerated, but like all PPIs, it can cause minor gastrointestinal and neurological side effects. **Why Nausea is correct:** The most common adverse effects of PPIs are gastrointestinal in nature, specifically **nausea**, diarrhea, and abdominal pain, followed closely by headache. In clinical trials and practice, nausea is frequently reported as the leading side effect, occurring in approximately 1-3% of patients. **Analysis of Incorrect Options:** * **B. Constipation:** While PPIs can occasionally cause changes in bowel habits, **diarrhea** is a much more common side effect than constipation due to alterations in gut flora and gastric pH. * **C. Jaundice:** Hepatotoxicity and jaundice are extremely rare idiosyncratic reactions associated with omeprazole. It is not considered a common or characteristic side effect. * **D. Black stools:** This is not a side effect of PPIs. Black, tarry stools (melena) usually indicate upper GI bleeding or the use of **Bismuth subsalicylate** or **Iron supplements**. In fact, PPIs are used to *treat* the conditions that cause black stools. **NEET-PG High-Yield Pearls:** * **Mechanism:** PPIs are prodrugs that require an acidic environment (activated in canaliculi) to form a reactive sulfenamide. * **Long-term risks:** Chronic use is associated with **Hypomagnesemia**, Vitamin B12 deficiency, increased risk of *C. difficile* infection, and osteoporotic fractures (due to decreased calcium absorption). * **Drug Interaction:** Omeprazole inhibits **CYP2C19**, which can decrease the activation of the antiplatelet drug **Clopidogrel**.

Question 94: Which of the following is NOT used in the treatment of Helicobacter pylori?

A. Colloid bismuth
B. Cisapride (Correct Answer)
C. Clarithromycin
D. Metronidazole

Explanation: **Explanation:** The treatment of *Helicobacter pylori* infection requires a combination of antibiotics and acid-suppressing agents to eradicate the bacteria and promote ulcer healing. **Why Cisapride is the correct answer:** **Cisapride** is a **prokinetic agent** that acts as a 5-HT₄ receptor agonist. It enhances gastric emptying and increases lower esophageal sphincter tone. While it was historically used for GERD and gastroparesis, it has **no antimicrobial activity** and plays no role in the eradication of *H. pylori*. Furthermore, it has been largely withdrawn or restricted due to the risk of serious cardiac arrhythmias (QT prolongation/Torsades de Pointes). **Why the other options are incorrect:** * **Colloid Bismuth (Option A):** Bismuth subsalicylate or subcitrate has direct toxic effects on *H. pylori*, prevents its adherence to the gastric mucosa, and inhibits its bacterial enzymes. It is a core component of **Bismuth-based Quadruple Therapy**. * **Clarithromycin (Option C):** A macrolide antibiotic that inhibits bacterial protein synthesis. It is the "backbone" of the standard **Triple Therapy** (PPI + Amoxicillin + Clarithromycin). * **Metronidazole (Option D):** An imidazole antibiotic used as an alternative to amoxicillin in penicillin-allergic patients or as part of quadruple therapy regimens. **NEET-PG High-Yield Pearls:** 1. **Standard Triple Therapy (7-14 days):** PPI + Clarithromycin + Amoxicillin (or Metronidazole). 2. **Bismuth Quadruple Therapy:** PPI + Bismuth + Metronidazole + Tetracycline (Treatment of choice in areas with high clarithromycin resistance). 3. **Diagnosis:** The **Urea Breath Test** is the gold standard for non-invasive diagnosis and confirming eradication. 4. **Sequential Therapy:** Involves 5 days of PPI + Amoxicillin, followed by 5 days of PPI + Clarithromycin + Tinidazole.

Question 95: Which antiemetic drug selectively blocks levodopa-induced vomiting without blocking its anti-Parkinsonian action?

A. Metoclopramide
B. Cisapride
C. Domperidone (Correct Answer)
D. Ondansetron

Explanation: ### Explanation **Correct Option: C. Domperidone** The Chemoreceptor Trigger Zone (CTZ), which triggers vomiting, is located in the *area postrema* of the medulla. While the CTZ is anatomically in the brain, it lies **outside the Blood-Brain Barrier (BBB)**. Levodopa, used in Parkinson’s disease, is converted to dopamine, which stimulates D2 receptors in the CTZ, causing nausea and vomiting [1]. **Domperidone** is a peripheral D2 receptor antagonist [2]. Because it **does not cross the BBB**, it effectively blocks D2 receptors in the CTZ (relieving vomiting) without interfering with the D2 receptors in the basal ganglia (preserving the anti-Parkinsonian effect) [1]. **Why other options are incorrect:** * **A. Metoclopramide:** This is a central D2 antagonist that **crosses the BBB**. It would block dopamine receptors in the basal ganglia, worsening Parkinsonian symptoms or causing Extrapyramidal Side Effects (EPS) [1]. * **B. Cisapride:** This is a prokinetic agent that acts primarily as a 5-HT4 agonist. It does not have significant D2-blocking activity and is not the drug of choice for levodopa-induced emesis. * **D. Ondansetron:** This is a 5-HT3 receptor antagonist [2]. While it is a potent antiemetic (especially for chemo-induced vomiting), it is not the specific pharmacological "antidote" for dopamine-mediated emesis in Parkinson’s patients. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Domperidone is the preferred antiemetic for patients on Levodopa or Bromocriptine. * **Side Effects:** Though it lacks EPS, Domperidone can still cause **hyperprolactinemia** (galactorrhea/gynecomastia) because the pituitary gland also lies outside the BBB. * **Cardiac Warning:** Intravenous domperidone is associated with **QT interval prolongation** and cardiac arrhythmias.

Question 96: Which of the following substances can cause relaxation of the lower esophageal sphincter?

A. Alcohol
B. Caffeine
C. Diazepam
D. Antacid (Correct Answer)

Explanation: **Explanation:** The **Lower Esophageal Sphincter (LES)** is a physiological high-pressure zone that prevents the reflux of gastric contents into the esophagus. Its tone is regulated by various hormones, neurotransmitters, and pharmacological agents. **Why Antacids are the Correct Answer:** Antacids (like Magnesium or Aluminum hydroxide) work by neutralizing gastric acid. This process **increases gastric pH**. A higher (more alkaline) pH in the stomach triggers the release of **Gastrin**. Gastrin is a potent hormone that **increases LES tone** (causes contraction). Therefore, by increasing pH and gastrin levels, antacids help prevent reflux by tightening the sphincter. **Analysis of Incorrect Options:** * **Alcohol:** It is a direct smooth muscle relaxant. It decreases LES pressure and delays gastric emptying, both of which promote Gastroesophageal Reflux Disease (GERD). * **Caffeine:** Found in coffee and tea, caffeine acts as a phosphodiesterase inhibitor, increasing cAMP levels in smooth muscles, which leads to **relaxation** of the LES. * **Diazepam:** As a benzodiazepine, it has muscle-relaxant properties. It decreases the resting pressure of the LES, potentially worsening reflux symptoms. **High-Yield Clinical Pearls for NEET-PG:** * **Drugs that INCREASE LES Tone (Good for GERD):** Metoclopramide, Domperidone (Prokinetics), Bethanechol (Cholinergic), and Gastrin. * **Drugs that DECREASE LES Tone (Cause/Worsen GERD):** Nitrates, Calcium Channel Blockers (CCBs), Theophylline, Anticholinergics, Tricyclic Antidepressants (TCAs), and Progesterone (reason for GERD in pregnancy). * **Surgical Note:** The surgical management of a relaxed LES (GERD) is **Nissen Fundoplication**.

Question 97: Which of the following drugs is not an antiemetic?

A. Ondansetron
B. Domperidone
C. Metoclopramide
D. Cinnarizine (Correct Answer)

Explanation: The question asks to identify the drug that is **not** primarily classified as an antiemetic. While several drugs have secondary anti-nausea properties, their primary pharmacological classification and clinical indication determine their category. **Why Cinnarizine is the correct answer:** Cinnarizine is primarily classified as a **Labyrinthine suppressant** and a **H1-receptor antagonist** with calcium channel blocking activity [1]. Its primary clinical use is in the management of **Vertigo** and **Motion Sickness** (prophylaxis) [1]. While it prevents nausea associated with motion, it is not used as a general-purpose antiemetic for post-operative, chemotherapy-induced, or drug-induced vomiting [1]. **Analysis of Incorrect Options:** * **Ondansetron:** A potent **5-HT3 receptor antagonist** [1, 2]. It is the gold standard for treating Chemotherapy-Induced Nausea and Vomiting (CINV) and Post-Operative Nausea and Vomiting (PONV) [1]. * **Domperidone:** A **peripheral D2 receptor antagonist** [1, 2]. It acts on the Chemoreceptor Trigger Zone (CTZ) but does not cross the blood-brain barrier, making it an effective antiemetic with fewer extrapyramidal side effects [1, 2]. * **Metoclopramide:** A **central and peripheral D2 antagonist** with prokinetic properties [1, 2]. It acts on the CTZ and increases lower esophageal sphincter tone, making it a versatile antiemetic [1, 2]. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for Motion Sickness:** Hyoscine (Scopolamine) is the most effective [1]; Cinnarizine is an alternative [1]. * **Drug of choice for CINV:** Ondansetron (often combined with Dexamethasone) [1]. * **Drug of choice for Morning Sickness (Pregnancy):** Doxylamine + Pyridoxine. * **Side Effect Note:** Metoclopramide can cause **Extrapyramidal Symptoms (EPS)** like acute dystonia due to central D2 blockade [1], whereas Domperidone carries a risk of **QT interval prolongation**.

Question 98: Which proton pump inhibitor can be administered intravenously?

A. Omeprazole
B. Rabeprazole
C. Pantoprazole (Correct Answer)
D. Fomepizole

Explanation: **Explanation:** **1. Why Pantoprazole is Correct:** Proton Pump Inhibitors (PPIs) are prodrugs that irreversibly inhibit the $H^+/K^+$ ATPase pump in gastric parietal cells. While most PPIs are administered orally, certain clinical scenarios (e.g., active upper GI bleeding, Zollinger-Ellison syndrome, or patients who are NPO) require parenteral administration. **Pantoprazole** and **Esomeprazole** are the most commonly used IV formulations globally. Pantoprazole is preferred in hospital settings due to its high stability in solution and established efficacy in maintaining a gastric pH > 6, which is critical for clot stabilization in peptic ulcer bleeding. **2. Analysis of Incorrect Options:** * **Omeprazole:** While an IV formulation of Omeprazole exists in some international markets, it is less commonly used than Pantoprazole due to stability issues. In the context of standard medical exams like NEET-PG, Pantoprazole is the classic "textbook" answer for IV PPIs. * **Rabeprazole:** This is a potent, fast-acting PPI, but it is primarily administered **orally**. It has a quicker onset of action than omeprazole but lacks a widely used intravenous preparation in standard clinical practice. * **Fomepizole:** This is a **distractor**. Fomepizole is not a PPI; it is a competitive inhibitor of **alcohol dehydrogenase** used as an antidote for methanol and ethylene glycol poisoning. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** PPIs are "hit and run" drugs; their plasma half-life is short (~1.5 hours), but their duration of action is long (24–48 hours) because they bind irreversibly to the proton pump. * **Activation:** They require an **acidic environment** (pKa) to be converted into the active sulfenamide form; hence, they should be taken 30 minutes before meals. * **Drug Interaction:** Omeprazole inhibits CYP2C19 and can decrease the activation of the antiplatelet drug **Clopidogrel**. Pantoprazole has the least potential for such drug interactions.

Question 99: Ranitidine differs from cimetidine in the following respect?

A. It is less potent
B. It is shorter acting
C. It does not have anti-androgenic action (Correct Answer)
D. It produces more CNS side effects

Explanation: ### Explanation Ranitidine and Cimetidine are both **H2-receptor antagonists** used to reduce gastric acid secretion. However, Ranitidine was developed as a second-generation agent to overcome the specific side-effect profile and pharmacokinetic limitations of Cimetidine. **Why Option C is Correct:** Cimetidine has a unique chemical structure that allows it to bind to androgen receptors, acting as an **anti-androgen**. It also inhibits the metabolism of estradiol. This leads to clinical side effects like **gynecomastia** in men and galactorrhea in women. **Ranitidine lacks this anti-androgenic activity**, making it a safer choice regarding endocrine side effects. **Analysis of Incorrect Options:** * **A. It is less potent:** Incorrect. Ranitidine is actually **5–10 times more potent** than cimetidine in inhibiting gastric acid secretion. * **B. It is shorter acting:** Incorrect. Ranitidine has a longer duration of action (8–12 hours) compared to cimetidine (6 hours), allowing for less frequent dosing. * **D. It produces more CNS side effects:** Incorrect. Cimetidine is more lipid-soluble and more likely to cross the blood-brain barrier, causing confusion or hallucinations, especially in the elderly. Ranitidine has negligible CNS penetration. **High-Yield NEET-PG Pearls:** 1. **Enzyme Inhibition:** Cimetidine is a potent **inhibitor of Cytochrome P450 (CYP450)** enzymes, leading to numerous drug interactions (e.g., increasing levels of Warfarin, Theophylline, Phenytoin). Ranitidine has a much lower affinity for CYP450. 2. **Potency Order:** Famotidine > Ranitidine > Cimetidine. 3. **Clinical Use:** While largely replaced by Proton Pump Inhibitors (PPIs) for PUD, H2 blockers are still high-yield for their role in treating **nocturnal acid breakthrough**.

Question 100: Granisetron is used in which of the following conditions?

A. Motion sickness
B. Sedation in endoscopy
C. Chemotherapy-induced nausea and vomiting (Correct Answer)
D. Gastroesophageal reflux disease

Explanation: **Explanation:** **Granisetron** is a potent, highly selective **5-HT₃ receptor antagonist**. These receptors are located peripherally on vagal nerve terminals in the gastrointestinal tract and centrally in the Chemoreceptor Trigger Zone (CTZ). By blocking these receptors, Granisetron effectively inhibits the emetic reflex triggered by serotonin release. **Why Option C is Correct:** The primary clinical indication for 5-HT₃ antagonists (the "-setron" family, including Ondansetron and Granisetron) is the prevention and treatment of **Chemotherapy-Induced Nausea and Vomiting (CINV)**, particularly for highly emetogenic drugs like Cisplatin. They are also the drugs of choice for **Post-operative Nausea and Vomiting (PONV)** and radiation-induced emesis. **Why Other Options are Incorrect:** * **A. Motion Sickness:** This is mediated by H₁ (histaminic) and M₁ (muscarinic) receptors in the vestibular system. 5-HT₃ antagonists are **ineffective** here. Drugs like Hyoscine (Scopolamine) or Promethazine are preferred. * **B. Sedation in endoscopy:** Granisetron has no sedative properties. Midazolam (a benzodiazepine) or Propofol are typically used for procedural sedation. * **D. GERD:** Treatment involves acid suppression (PPIs like Omeprazole) or prokinetics (like Metoclopramide). Granisetron does not significantly affect gastric acid secretion or lower esophageal sphincter tone. **NEET-PG High-Yield Pearls:** * **Side Effects:** The most common side effects are **headache** and constipation. * **ECG Changes:** They can cause **QT interval prolongation** (caution in patients with arrhythmias). * **Comparison:** Granisetron is more potent and has a longer duration of action than Ondansetron. * **Palonosetron:** This is a second-generation 5-HT₃ antagonist with a much longer half-life (~40 hours), used for delayed emesis.

Practice by Chapter

Acid-Peptic Disease Therapeutics

Practice Questions

Proton Pump Inhibitors

Practice Questions

H2 Receptor Antagonists

Practice Questions

Antacids and Mucosal Protectants

Practice Questions

Antiemetics

Practice Questions

Prokinetic Agents

Practice Questions

Laxatives and Purging Agents

Practice Questions

Antidiarrheal Drugs

Practice Questions

Drugs for Inflammatory Bowel Disease

Practice Questions

Pancreatic Enzyme Supplements

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free